本文言語 | 英語 |
---|---|
ページ(範囲) | 106-108 |
ページ数 | 3 |
ジャーナル | Journal of Cutaneous Immunology and Allergy |
巻 | 5 |
号 | 3 |
DOI | |
出版ステータス | 出版済み - 6月 2022 |
!!!All Science Journal Classification (ASJC) codes
- 免疫アレルギー学
- 皮膚病学
引用スタイル
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Cutaneous Immunology and Allergy, Vol. 5, No. 3, 06.2022, p. 106-108.
研究成果: ジャーナルへの寄稿 › レター › 査読
}
TY - JOUR
T1 - Impact of physicians' clinical experience and workplace on patients' care of urticaria in Japan
T2 - A sub-analysis of a nation-wide cross-sectional web questionnaire survey
AU - Takahagi, Shunsuke
AU - Kamegashira, Akiko
AU - Inomata, Naoko
AU - Fukunaga, Atsushi
AU - Nakahara, Takeshi
AU - Hayama, Koremasa
AU - Hide, Michihiro
N1 - Funding Information: We appreciate the members of the Japanese Society for Cutaneous Immunology and Allergy for their participation in the survey. We also thank Dr. Faiz Kermani for his review of the manuscript. Funding Information: ST reports speaker's fee from Novartis Pharma. MH reports speaker's fee from Taiho Pharmaceutical, Novartis Pharma, and Mitsubishi‐Tanabe. TN reports speaker's fee from Maruho Co., Ltd., and Sanofi, K.K., and belonging to the endowed division sponsored by Maruho Co., Ltd. AF reports speaker's fee from Taiho Pharmaceutical and Novartis Pharma, and research funding from Taiho Pharmaceutical. KH reports speaker's fee from Kaken Pharmaceutical, Kyorin, Meiji Seika Pharma, Mitsubishi‐Tanabe, Novartis Pharma, Sanofi, Taiho Pharmaceutical, and research grants from Kaken Pharmaceutical, Mitsubishi‐Tanabe, and Taiho Pharmaceutical.
PY - 2022/6
Y1 - 2022/6
UR - http://www.scopus.com/inward/record.url?scp=85118995054&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118995054&partnerID=8YFLogxK
U2 - 10.1002/cia2.12220
DO - 10.1002/cia2.12220
M3 - Letter
AN - SCOPUS:85118995054
SN - 2574-4593
VL - 5
SP - 106
EP - 108
JO - Journal of Cutaneous Immunology and Allergy
JF - Journal of Cutaneous Immunology and Allergy
IS - 3
ER -